INGREDIENTS
Each tablet contains Sustained release Trimetazidine Dihydrochloride 60mg

CATEGORY
Antiischemic, antianginal

INDICATION
1. Newly diagnosed anginal patients
2. Anginal patients not well controlled by conventional antianginal agents
3. In Anginal patients, when conventional antianginal agents lead to unwanted side effects
4. In anginal patients apparently well controlled by conventional antianginal agents (as the risk of silent ischemia remains.)

DOSAGE
One tablet daily

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.